Chen Hang, Li Molin, Huang Ping
National Key Clinical Department, Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing 400000, P.R. China.
J Cancer. 2019 Jun 9;10(15):3571-3581. doi: 10.7150/jca.28428. eCollection 2019.
Long non-coding RNA (lncRNA) and microRNA (miRNA) play an important role in genesis and progression of tumors. The aim of this study was to explore the expression, biological function and molecular mechanism of small nucleolar RNA host gene 16 (SNHG16) in HCC. RT-qPCR was conducted to evaluate the expression level of SNHG16 in HCC tissues and cell lines. Our findings showed for the first time that SNHG16 was up-regulated in HCC tissues and cell lines. The expression of SNHG16 in cancer tissues was highly correlated with tumor size, TNM stage, ALT expression level and HBV DNA level. Moreover, cell proliferation, migration and invasion were detected by CCK-8 assay, transwell migration assay and transwell invasion assay, respectively. Xenograft tumor experiment was used to determine the biological function of SNHG16 . As revealed by our data, SNHG16 accelerated the proliferation, migration and invasion of HCC cell. SNHG16 facilitated tumor formation . Next, the relationship between SNHG16, miR-186 and ROCK1 were analyzed using bioinformatics analysis, qRT-PCR, luciferase reporter assay and western blot. Further molecular mechanism studies reported that the expression of SNHG16 was negatively correlated with the level of miR-186 and SNHG16 directly bound to miR-186. SNHG16 and miR-186 repressed each other. Notably, rescue experiments were conducted and showed that miR-186 reversed the effect of SNHG16 on cell. Taken together, SNHG16 promoted HCC cell proliferation, migration and invasion by functioning as a competitive endogenous RNA (ceRNA) to negatively regulate miR-186 expression. Our data suggested that SNHG16 might be a potential biomarker and a new therapeutic target for HCC.
长链非编码RNA(lncRNA)和微小RNA(miRNA)在肿瘤的发生和发展中发挥着重要作用。本研究旨在探讨小核仁RNA宿主基因16(SNHG16)在肝癌中的表达、生物学功能及分子机制。采用逆转录-定量聚合酶链反应(RT-qPCR)检测肝癌组织和细胞系中SNHG16的表达水平。我们的研究结果首次表明,SNHG16在肝癌组织和细胞系中上调。SNHG16在癌组织中的表达与肿瘤大小、TNM分期、谷丙转氨酶(ALT)表达水平和乙肝病毒(HBV)DNA水平高度相关。此外,分别通过细胞计数试剂盒-8(CCK-8)法、Transwell迁移试验和Transwell侵袭试验检测细胞增殖、迁移和侵袭能力。采用异种移植肿瘤实验来确定SNHG16的生物学功能。我们的数据显示,SNHG16促进了肝癌细胞的增殖、迁移和侵袭。SNHG16促进肿瘤形成。接下来,使用生物信息学分析、qRT-PCR、荧光素酶报告基因试验和蛋白质免疫印迹法分析SNHG16、miR-186和Rho相关卷曲螺旋蛋白激酶1(ROCK1)之间的关系。进一步的分子机制研究表明,SNHG16的表达与miR-186的水平呈负相关,且SNHG16直接与miR-186结合。SNHG16与miR-186相互抑制。值得注意的是,进行了挽救实验,结果表明miR-186逆转了SNHG16对细胞的作用。综上所述,SNHG16作为竞争性内源性RNA(ceRNA)负向调节miR-186的表达,从而促进肝癌细胞的增殖、迁移和侵袭。我们的数据表明,SNHG16可能是肝癌的潜在生物标志物和新的治疗靶点。